Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + RAD001 in Urothelial Carcinoma
NCT00933374Phase 2Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jul 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in urothelial carcinoma (UC), sponsored by Heinrich Heine University Düsseldorf. Started Jul 2009; status: terminated.
02
Drugs
everolimus
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00933374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933374.